Would you offer endocrine therapy to a patient who developed a new contralateral pT1b pN0 ER/PR+ HER2- breast IDC 1 year after coming off 10 years of anastrozole for prior invasive breast cancer?

Answer from: Medical Oncologist at Academic Institution

I would offer the patient endocrine therapy but would use a different endocrine agent than one the patient had been on for the previously diagnosed contralateral breast cancer. Since this patient was on anastrozole for 10 years (a non-steroidal aromatase inhibitor), I would probably choose a steroid...

Comments

Medical Oncologist at Cancer Center Overlook Hospital
Couldn’t you make the argument that this can...

Medical Oncologist at Colorado Permanente Medical Group Hematology & Oncology
What about good ole tamoxifen? Or checking for ESR...

Medical Oncologist at Texas Oncology
Checking for ESR1 seems to make sense. Otherwise, ...

Answer from: Medical Oncologist at Community Practice

Yes, absolutely - would offer endocrine therapy for this new ER/PR+ breast cancer that developed a year after stopping prior AI.

Please select the option that best describes you:

Would you offer endocrine therapy to a patient who developed a new contralateral pT1b pN0 ER/PR+ HER2- breast IDC 1 year after coming off 10 years of anastrozole for prior invasive breast cancer?

Related Questions